C. L. Soderberg

发表

TBX2 is preferentially amplified in BRCA1- and BRCA2-related breast tumors.

Fergus J Couch, Lynn Hartmann, Thomas A Sellers, 2002, Cancer research.

Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell‐mediated restoration of normal human chromosome 19

K. Ballman, R. Jenkins, C. Giannini, 2009, Genes, chromosomes & cancer.

Mapping of the chromosome 19 q‐arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

B. Scheithauer, D. Louis, H. Mohrenweiser, 2000, Genes, chromosomes & cancer.

Advances in Brief TBX 2 Is Preferentially Amplified in BRCA 1-and BRCA 2-related Breast Tumors 1

T. Sellers, D. Schaid, F. Couch, 2002 .

Mapping of the chromosome 19 q‐arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers

B. Scheithauer, D. Louis, H. Mohrenweiser, 2000 .

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers.

T. Sellers, D. Schaid, F. Couch, 2001, Journal of the National Cancer Institute.

ERBB2, TBX2, RPS6KB1, and MYC alterations in breast tissues of BRCA1 and BRCA2 mutation carriers

Daniel J Schaid, Fergus Couch, Jeffrey M Slezak, 2004, Genes, chromosomes & cancer.

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

Daniel J Schaid, Jeffrey L Myers, Jeffrey M Slezak, 2003, Cancer.

Microsatellite instability in hereditary and sporadic breast cancers

S. Thibodeau, L. Hartmann, J. Cunningham, 2003, International journal of cancer.